期刊文献+

尿细胞学、NMP22和B超联合检查在膀胱癌患者随访中的应用 被引量:2

Combined use of urine cytology urine nuclear matrix protein22(NMP22) and transabdominal ultrasonography in the follow up study of bladder cancer
下载PDF
导出
摘要 目的 :了解联合应用尿细胞学、尿核基质蛋白 2 2 (NMP2 2 )、经腹B超检查在膀胱癌术后患者随访中的价值。方法 :对 36例膀胱癌术后随访患者先行尿细胞学、尿NMP2 2、经腹B超检查 ,再行膀胱镜检查 ,以膀胱镜检查及活检为金标准 ,分析各种检查结果。结果 :36例经膀胱镜检查及活检证实肿瘤复发 17例。尿细胞学、尿NMP2 2、经腹B超检查的灵敏度分别为 4 7.1%、82 .4 %和 70 .6 %。三种检查联合应用的灵敏度为 94 .1% ,与膀胱镜检查比较差别无显著性意义。结论 :尿细胞学、尿NMP2 2。 Purpose:To evaluate the combined use of urine cytology,urine nuclear matrix protein 22(NMP22)test and transabdominal ultrasonography for the flollow up study of bladder cancer.Methods:Urine cytology,NMP22 and transabdominal ultrasonography were carried out for 36 cases of bladder cancer as follow up studies after surgical treatment. Cystoscopic and biopsy findings were used as the golden standard for the evaluation of the above 3 procedures.Results:Of the 36 patients, tumor recurrence occeurred in 17 on cystoscopy. The sensitivety of urine cytology, NMP22 and transabdominal ultrasonography were 47.1 %, 82.4 %, 70.6 % respectively. With combined use of the 3 methods, the sensitivity were 94.1 %.Conclusions:The combined use of urine cytology, NMP22 and transabdominal ultrasonography can elevate the sensitivity of the diagnosis of bladder cancer recurrence after operation.
作者 邵春南
出处 《临床泌尿外科杂志》 2003年第2期72-74,共3页 Journal of Clinical Urology
关键词 尿细胞学 NMP22 B超 联合 检查 膀胱癌 Bladder neoplasms Carcinoma Follow up studies
  • 相关文献

参考文献11

  • 1[2]Getzenberg R H.The nuclear matrix and the regulation of gene expression, tissue specificity. J Cell Biochem,1994,55: 22-31.
  • 2[3]Keesee K, Bnigman J V,Thill G,et al. Utilization of nuclear matrix proteins for cancer diagnosis . CRC Crit Eukaryotic Gme Exp, 1996, 6: 189-214.
  • 3[4]Marta S C, Enrique H, Julian M, et al.Comparative sensitivituy of uninary CYFRA 21-1, urinary bladder canaer antigen, tissue polypeptide antigen and NMP22 to detect bladder cancer.J Urol ,1999, 162: 1951-1956.
  • 4[5]Miyanaga N,Akaza H, Ishikawa S, et al.Clinical of nuclear matrix protein22s (NMP22) inurine as a novel marker for urotheial cancer. Euro Urol, 1997, 31: 163-168.
  • 5[6]Zippe C, Pandrangi L, Agarwal A.NMP22 is a sensitive cost-effective test in patients at risk for bladder cancer. J Urol, 1999, 161:62-65.
  • 6李淑清,山岗志,郭应禄.经腹壁超声在膀胱肿瘤诊断与分期中的意义[J].中华泌尿外科杂志,1996,17(6):362-363. 被引量:23
  • 7[8]Juul N,Pederson S T,Larsen S T,et al,Bladder tumor control by abdominal ultrasound and urine cytology. Scand J Urol Nephrol, 1986, 20:275-278.
  • 8[9]Davies A H,Cranston D,Tumer W H,et al.Therole of abdominal and transrectal ultrasound and cytology in The detection ofrecunent bladder tumors. Eur Urol ,1990, 18:124-126.
  • 9[10]Berlac P A,Holm H H.Bladder tumor control by abdominl ultrasound and urine cytology.J Urol,1992, 147:1510-1512.
  • 10[11]Brun B,Gammelgaard J,Christoffersen J,et al.Transabdominal dynami C ultrasonography in detection of bladder tumors.J Urol,1984,132:19-20.

二级参考文献3

  • 1魏东,中华泌尿外科杂志,1993年,14卷,267页
  • 2李炎康,中华泌尿外科杂志,1988年,9卷,51页
  • 3史启铎,中华泌尿外科杂志,1988年,9卷,15页

共引文献22

同被引文献40

  • 1Ramakumar S, Bhuiyan J, Besse J A, et al. Comparison of screening methods in the detection of bladder cancer. J Urol,1999,161:388-394.
  • 2Soloway M S,Briggman J V,Carpinito G A,et al.Use of a new tumor marker, urinary NMP22,in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol,1996,159:363-367.
  • 3Landis S K, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin,1998,48:6-29.
  • 4Getzenberg R H,Konety B R,Oeler T A,et al.Bladder cancer associated nuclear matrix proteins.Cancer Res,1996,56:1690-1694.
  • 5Keesee K,Brigman J V,Thill G,et al.Utilization of nuclear matrix proteins for cancer diagnosis.CRC Crit Eukaryotic Gene Exp,1996,6:189-214.
  • 6Martin B ,Tatiana B ,Ahmad S ,et al. Current concepts in biomarker technology for bladder cancers [ J ]. Clin Chem,2000,46 (5) :595.
  • 7Messing EM. Urothelial tumors of the urinary tract [ M ]. Campbell' s urology. 8th ed. Philadelphia ( PA ) : W. B.Saunders ,2002:2732 - 2784.
  • 8Jalil H, Ali RG, Mohammad MM, et al. Detection of recurrent bladder cancer NMP22 test or urine cytology [ J]. J Urol,2012, 9(1) :367 -372.
  • 9Burke DM, Shaekley DC, O' Reilly PH. The community-based morbidity of flexible cystoscopy [ J ]. BJU Int,2002,89 (4) : 347 - 349.
  • 10Berezney R. The nuelear matrix : a heuristic model for investig- ating genomic organization and function in the cell nucleus [ J ]. J Cell Bioehem, 1991,47 (2) : 109 - 123.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部